Trial site
Lisbon
- 9running trials
- 9closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Multiple sclerosis4 trials
- Chronic myeloid leukaemia3 trials
- Familial hypercholesterolaemia3 trials
- Heart failure2 trials
- Acute myeloid leukaemia1 trial
- Aortic stenosis1 trial
- Aplastic anaemia1 trial
- Childhood cancers1 trial
- Coronary artery disease1 trial
- High blood pressure1 trial
- Lung cancer1 trial
- Macular degeneration1 trial
- and 8 more
- Phase
- Phase 310 trials
- Phase 24 trials
- Phase 1/21 trial
- Phase 41 trial
- Status
- Completed6 trials
- Active, not recruiting5 trials
- Recruiting4 trials
- Terminated3 trials
- Lead sponsor
- Novartis Pharmaceuticals18 trials
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Ofatumumab in Portuguese Multiple Sclerosis Patients - an Observational Study
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple sclerosis2 recruiting
- Aortic stenosis1 recruiting
- Familial hypercholesterolaemia1 recruiting
- Heart failure1 recruiting
- High blood pressure1 recruiting
- Pulmonary arterial hypertension1 recruiting
Closed trials
Terminated
Completed
Study of Safety and Tolerability of CFZ533 in Patients With Sjögren's Syndrome
Terminated
Completed
Completed
Completed
Completed
Terminated
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026